305 related articles for article (PubMed ID: 36048410)
1. What's New in Topicals for Atopic Dermatitis?
Kleinman E; Laborada J; Metterle L; Eichenfield LF
Am J Clin Dermatol; 2022 Sep; 23(5):595-603. PubMed ID: 36048410
[TBL] [Abstract][Full Text] [Related]
2. Topical agents for the treatment of atopic dermatitis.
Diaz A; Guttman-Yassky E
Expert Rev Clin Immunol; 2019 Apr; 15(4):369-382. PubMed ID: 30587053
[TBL] [Abstract][Full Text] [Related]
3. Emerging systemic therapies for atopic dermatitis: oral small molecules and targeted topical agents.
Nusbaum KB; Nguyen CM; Fleischer AB
J Dermatolog Treat; 2022 May; 33(3):1274-1278. PubMed ID: 33143506
[TBL] [Abstract][Full Text] [Related]
4. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
5. [Development of new topical substances for the treatment of atopic dermatitis].
Freimooser S; Traidl S; Werfel T
Dermatologie (Heidelb); 2022 Jul; 73(7):514-519. PubMed ID: 35608634
[TBL] [Abstract][Full Text] [Related]
6. New Non-Steroidal Topical Therapies for Inflammatory Dermatoses-Part 3: Roflumilast.
DiRuggiero M; Mancuso-Stewart E; DiRuggiero D; Zirwas M
Skinmed; 2023; 21(4):264-268. PubMed ID: 37771017
[TBL] [Abstract][Full Text] [Related]
7. New Topical Therapies in Development for Atopic Dermatitis.
Freitas E; Gooderham M; Torres T
Drugs; 2022 Jun; 82(8):843-853. PubMed ID: 35596877
[TBL] [Abstract][Full Text] [Related]
8. New and Emerging Therapies for Pediatric Atopic Dermatitis.
Nguyen HL; Anderson KR; Tollefson MM
Paediatr Drugs; 2019 Aug; 21(4):239-260. PubMed ID: 31364023
[TBL] [Abstract][Full Text] [Related]
9. Review of Atopic Dermatitis and Topical Therapies.
Mayba JN; Gooderham MJ
J Cutan Med Surg; 2017; 21(3):227-236. PubMed ID: 28300440
[TBL] [Abstract][Full Text] [Related]
10. Evaluating topical JAK inhibitors as a treatment option for atopic dermatitis.
Fardos MI; Singh R; Perche PO; Kelly KA; Feldman SR
Expert Rev Clin Immunol; 2022 Mar; 18(3):221-231. PubMed ID: 34637367
[TBL] [Abstract][Full Text] [Related]
11. Delgocitinib in atopic dermatitis.
Ho J; Molin S
Drugs Today (Barc); 2021 Dec; 57(12):719-731. PubMed ID: 34909801
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
Frankel HC; Qureshi AA
Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
[TBL] [Abstract][Full Text] [Related]
13. Topical Prescription Management.
Lovell K; Ackerson B; Thorpe R; Nicholas M
Adv Exp Med Biol; 2024; 1447():117-129. PubMed ID: 38724789
[TBL] [Abstract][Full Text] [Related]
14. Topical Agents for the Treatment of Atopic Dermatitis.
Eichenfield LF; Luger T; Papp K; Silverberg JI; Sierka D; Zang C; Tallman AM; Zielinski MA; Ports WC
J Drugs Dermatol; 2020 Jan; 19(1):50-64. PubMed ID: 31985912
[TBL] [Abstract][Full Text] [Related]
15. Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies.
Zane LT; Chanda S; Jarnagin K; Nelson DB; Spelman L; Gold LS
Immunotherapy; 2016 Jul; 8(8):853-66. PubMed ID: 27283509
[TBL] [Abstract][Full Text] [Related]
16. Difamilast for the treatment of atopic dermatitis.
Freitas E; Torres T
J Int Med Res; 2023 Jun; 51(6):3000605231169445. PubMed ID: 37389929
[TBL] [Abstract][Full Text] [Related]
17. Guidelines of care for the management of atopic dermatitis in adults with topical therapies.
Sidbury R; Alikhan A; Bercovitch L; Cohen DE; Darr JM; Drucker AM; Eichenfield LF; Frazer-Green L; Paller AS; Schwarzenberger K; Silverberg JI; Singh AM; Wu PA; Davis DMR
J Am Acad Dermatol; 2023 Jul; 89(1):e1-e20. PubMed ID: 36641009
[TBL] [Abstract][Full Text] [Related]
18. Topical Agents Currently in Phase II or Phase III Trials for Atopic Dermatitis.
Uppal SK; Chat VS; Kearns DG; Wu JJ
J Drugs Dermatol; 2020 Oct; 19(10):956-959. PubMed ID: 33026767
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Profile of Difamilast, a Novel Selective Phosphodiesterase 4 Inhibitor, for Topical Treatment of Atopic Dermatitis.
Hiyama H; Arichika N; Okada M; Koyama N; Tahara T; Haruta J
J Pharmacol Exp Ther; 2023 Jul; 386(1):45-55. PubMed ID: 37041087
[TBL] [Abstract][Full Text] [Related]
20. New molecules for atopic dermatitis treatment beyond biological therapy.
Freitas E; Torres T
Curr Opin Allergy Clin Immunol; 2023 Jun; 23(3):210-215. PubMed ID: 37185825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
